• SP600125: Applied JNK Inhibitor Workflows in Inflammation Re

  2026-06-29

  Harness the selectivity of SP600125 for dissecting JNK-driven inflammation, apoptosis, and cytokine modulation in cell and animal models. This article translates recent mechanistic insights and protocol refinements into actionable steps for reliable experimental outcomes.

• Cytarabine (AraC): Mechanistic Insights and Resistance in Le

  2026-06-29

  Explore the advanced mechanistic roles of Cytarabine (AraC) in leukemia research, focusing on DNA synthesis inhibition, resistance mechanisms, and the intersection with viral cell death modulation. This article uniquely bridges apoptosis pathways and recent viral immunology findings for deeper experimental insight.

• DiscoveryProbe FDA-approved Drug Library: Mechanisms & Bench

  2026-06-28

  The DiscoveryProbe FDA-approved Drug Library (SKU: L1021) offers 2,320 rigorously characterized, clinically approved compounds for high-throughput pharmacological screening. This resource enables robust drug repositioning screening and target identification across cancer and neurodegenerative disease models. Its format and curation support reproducible, mechanism-driven research.

• Improved In Vitro Drug Response Evaluation in Cancer Researc

  2026-06-27

  Schwartz’s dissertation introduces a dual-metric framework to disentangle proliferative arrest from cell death in in vitro anti-cancer drug studies. This refined approach reveals the nuanced effects of agents like Bortezomib (PS-341), enabling more precise characterization of drug responses and informing both mechanistic and translational oncology research.

• SERCA2 Dysfunction Drives Pulmonary Vascular Remodeling via

  2026-06-26

  This study uncovers how SERCA2 dysfunction in pulmonary artery smooth muscle cells (PASMCs) initiates inflammation and vascular remodeling by downregulating the PPARγ/PGC1α/Nrf2 axis. The findings link oxidative stress to pulmonary hypertension pathogenesis and identify therapeutic opportunities targeting redox signaling.

• Cyclophosphamide: Translational Insights for Oncology Resear

  2026-06-26

  Explore how Cyclophosphamide, a cornerstone alkylating chemotherapeutic agent, bridges mechanistic insight with strategic protocol design for translational researchers in cancer and immune modulation. This article integrates high-impact evidence, advanced experimental guidance, and competitive landscape analysis, while highlighting APExBIO's rigorously characterized Cyclophosphamide (SKU A2343) as a translational research engine.

• Afatinib (BIBW 2992) in Advanced Tumor Assembloid Models

  2026-06-25

  Afatinib (BIBW 2992) is redefining targeted therapy research by enabling precise, irreversible inhibition of EGFR, HER2, and HER4 within physiologically complex assembloid models. Its robust solubility and proven activity against resistant mutations empower researchers to dissect tumor–stroma interactions and drug resistance mechanisms with unprecedented fidelity.

• Cell Cycle Assay Kit (K2263): High-Fidelity Analysis in Canc

  2026-06-25

  Discover how the Cell Cycle Assay Kit empowers advanced cell cycle phases analysis (G0/G1, S, G2/M) and apoptosis detection with scientific rigor. This article explores unique assay insights and practical innovations for cutting-edge cancer research.

• Toremifene Citrate: 20 Years of Clinical Insight in Breast C

  2026-06-24

  The referenced review synthesizes two decades of clinical experience with Toremifene Citrate as an oral selective estrogen receptor modulator (SERM) in breast cancer treatment. The study highlights Toremifene's efficacy, its distinct pharmacokinetics compared to tamoxifen, and implications for personalized medicine in hormone receptor-positive breast cancer.

• Sulfo-NHS-Biotin: Precision Protein Labeling for CNS Vascula

  2026-06-23

  Sulfo-NHS-Biotin streamlines cell surface protein labeling with unmatched aqueous solubility and amine selectivity, crucial for advanced CNS vascular research. This guide translates recent experimental breakthroughs into actionable workflows and troubleshooting strategies for high-sensitivity biotinylation.

• FK866 (APO866): Advanced NAMPT Inhibition for Cancer Researc

  2026-06-23

  FK866 (APO866) empowers researchers to dissect metabolic vulnerabilities in hematologic and solid tumor models with unmatched specificity. This guide translates the latest mechanistic discoveries and workflow optimizations into reproducible, high-impact protocols for NAD metabolism and apoptosis studies.

• Annexin V-PE Reagent: Streamlined Early Apoptosis Detection

  2026-06-22

  Annexin V-PE Reagent empowers researchers with rapid, sensitive, and reproducible detection of early apoptosis, crucial for applications ranging from CAR-T optimization to high-throughput cell death assays. Leveraging structural insights into CD38 targeting, this workflow-ready tool from APExBIO ensures reliable results even in challenging immunotherapy models.

• Otilonium Bromide: Advanced Antimuscarinic Agent for Experim

  2026-06-22

  Explore the unique role of Otilonium Bromide as an advanced antimuscarinic agent for dissecting cholinergic signaling pathways in neuroscience and smooth muscle pharmacology research. This article delivers a mechanistic deep dive, protocol guidance, and evidence-based comparisons to existing approaches.

• EdU Flow Cytometry Assay Kits (Cy3): Advanced S-Phase Detect

  2026-06-21

  Unlock denaturation-free, multiplex-capable cell proliferation analysis with EdU Flow Cytometry Assay Kits (Cy3). This guide details best practices, protocol parameters, and troubleshooting for robust DNA synthesis measurement—even in complex cancer research workflows.

• Pam3CSK4 TFA: Advanced Insights into TLR1/2 Activation and T

  2026-06-20

  Explore the advanced scientific mechanisms of Pam3CSK4 TFA, a potent TLR1/2 agonist, and its unique applications in translational immunology research. Gain new perspectives on cytokine profiling and maternal-neonatal immunity, grounded in the latest evidence.

421 records 11/29 page Previous Next First page 上5页 1112131415 下5页 Last page